Phoenix Education Partners' Q2 2026 results showed stable revenue, improved retention, a higher B2B mix, and margin expansion ...

When Ben Sasse announced last December that he had been diagnosed with Stage 4 pancreatic cancer, he called it a death ...

The former senator wants to heal the America he’s leaving behind.

Presidents give poor marks to higher ed on rebuilding public trust, yet may be overrelying on institutional messaging in ...

While the researchers only tricked Apple Intelligence into cursing at users, this same technique could be abused to ...

Your feed has gotten a little boring anyway... View Entire Post › ...

Detailed price information for Ascendis Pharma ADR (ASND-Q) from The Globe and Mail including charting and trades.

AI is coming—or rather is already here and increasingly used by Wall Street institutions and individuals alike.

“OpenClaw is essentially an agent framework. Underneath it is an agent that can write code, deployed on a cloud server or a ...

Bloomberg Law columnist David Lat spoke for our podcast, On The Merits, about why recent changes in the methodology for ...

YUVIWEL was granted orphan drug exclusivity by U.S. FDA to increase linear growth in pediatric patients 2 years of age and older with achondroplasia with open epiphyses - YUVIWEL is now commercially ...